Abstract: Chronic fatigue syndrome: new evidence for a central fatigue disorder

Clin Sci (Lond) 2003 Apr 23; [epub ahead of print]

Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP.

Considerable evidence points towards a prominent role for central neural (CNS) mechanisms in the pathogenesis of chronic fatigue syndrome (CFS), a disorder characterised chiefly by persistent, often debilitating, fatigue.

We wished to characterise circulating profiles of putative amino acid modulators of CNS serotoninergic and dopaminergic function in CFS patients at rest, during symptom-limited exercise and subsequent recovery. Twelve CFS patients and eleven age- and sex-matched sedentary controls, with similar physical activity histories, underwent ramp-incremental exercise to the limit of tolerance.

Plasma amino acid concentrations, oxygen uptake (Vo 2) and ratings of perceived exertion (RPE) were measured at rest, during exercise and recovery. Peak oxygen uptake (Vo 2peak) was significantly lower in the CFS patients, compared to controls. RPE in the patients was higher at all measured time points, including rest, relative to controls. Levels of free tryptophan [free Trp];the rate-limiting serotoninergic precursor, were significantly higher in CFS patients at exhaustion and recovery, whereas concentrations of branched-chain and large-neutral amino acids (BCAA and LNAA, respectively) were lower in patients at exhaustion and, for [LNAA], also during recovery.

Consequently, the [free Trp] : [BCAA] and [free Trp] : [LNAA] ratios were significantly higher in CFS patients, except at rest. On the other hand, levels of tyrosine, the rate-limiting dopaminergic precursor, were significantly lower at all time points in the patients. The significant differences observed in a number of key putative CNS serotoninergic and dopaminergic modulators, coupled with the exacerbated effort perception, provide further evidence for a potentially significant role of CNS mechanisms in CFS pathogenesis.

PMID: 12708966 [PubMed – as supplied by publisher]

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave a Reply